James C. Fredenburgh
1280 Main St. W
Hamilton, ON L8S4L7, Canada
Hamilton, ON L8S4L7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Poly(sulfobetaine-co-oligoethylene Glycol Methyl Ether Methacrylate) Copolymers with Improved Anti-Fouling and Anti-Coagulant Properties.
Journal: Biomacromolecules
Published: June 19, 2026
COMPARISON OF THE EFFECTS OF ABELACIMAB, ASUNDEXIAN, AND MILVEXIAN ON MEDICAL DEVICE-INDUCED CLOTTING AND THROMBIN GENERATION IN VITRO.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 18, 2026
In vitro comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation.
Journal: Research and practice in thrombosis and haemostasis
Published: March 18, 2026
Left Atrial Appendage Thrombosis in Patients With Atrial Fibrillation.
Journal: JACC. Clinical electrophysiology
Published: March 17, 2026
Long-Term Hydrophilic, Anti-Clotting, and Anti-Fibrotic Dynamic Covalent Silicone-Based Biomaterials.
Journal: Advanced healthcare materials
Published: February 21, 2026
Formation of a ternary polyphosphate-thrombin-fibrin complex attenuates thrombin activity.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 18, 2025
Antibody BAY3018250 against antiplasmin enhances plasminogen activation in vitro and thrombolysis in rabbits.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 25, 2025
DOAC-Stop reverses the anticoagulant effect of asundexian and milvexian.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 03, 2025
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 14, 2025
Last Updated: 09/26/2026